BioSpace News Archive

FDA

FDA Approves EYLEA® (aflibercept) Injection Prefilled Syringe

EYLEA is the only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syring

August 13, 2019

·

9 min read

Business

Corinth MedTech Appoints Steven Duddy as New President and CEO

He assumes day-to-day leadership of the Company and will also join the Corinth MedTech’s Board of Directors.

August 13, 2019

·

2 min read

BioCapital

Landos Biopharma Completes $60 Million Series B Financing

RTW Investments joins existing investor Perceptive Advisors in leading financing with a strong syndicate

August 13, 2019

·

6 min read

Business

Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic

Extended collaboration leveraging Schrödinger’s computational platform includes new terms with increased and additional milestone payments to Schrödinger

August 13, 2019

·

2 min read

Drug Development

Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors

Data from Phase 1 Study Supports Ongoing INTRIGUE Phase 3 Clinical Study in Patients with Second-line GIST

August 13, 2019

·

11 min read

Business

ProMIS Neurosciences Announces Second Quarter 2019 Results

Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer’s, ALS and Parkinson’s disease

August 13, 2019

·

9 min read

Business

Alnylam Pharmaceuticals and Ironwood Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP)

lnylam Pharmaceuticals, Inc. and Ironwood Pharmaceuticals, Inc. announced a U.S. GI disease education and promotional agreement for Alnylam’s givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 (ALAS1) for the potential treatment of AHP.

August 13, 2019

·

11 min read

Business

BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

Financial results for its first quarter of fiscal year 2020, ended June 30, 2019.

August 13, 2019

·

10 min read

BioMidwest

Cresco Labs Announces Listing on Frankfurt Stock Exchange

The Company’s shares continue to be listed on the Canadian Securities Exchange under the symbol “CL” and on the OTCQX under the symbol “CRLBF.”

August 13, 2019

·

4 min read

Pharm Country

Feinstein Institutes trial finds promising non-invasive therapy for stroke

Feinstein Institutes for Medical Research scientists are the first to publish clinical trial results of an investigational, non-invasive medical device for the treatment of spasticity in patients having experienced a stroke.

August 13, 2019

·

4 min read